Systems-level view of cocaine addiction: The interconnection of the immune and nervous systems

Experimental Biology and Medicine

Volumn 239, Issue 11, 2014, Pages 1433-1442

  Marasco, Christina C ^a,b   Goodwin, Cody R ^a,c   Winder, Danny G ^c   Schramm Sapyta, Nicole L ^d   McLean, John A ^a,c   Wikswo, John P ^a,b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

addiction; Cocaine; immune system; metabolism; nervous system; signaling

Indexed keywords

MONOAMINE; SIGMA 1 OPIATE RECEPTOR;

AGING; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM FUNCTION; COCAINE DEPENDENCE; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; METABOLIC REGULATION; MONOAMINE METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; DRUG EFFECTS; NERVOUS SYSTEM; PATHOPHYSIOLOGY; SYSTEMS BIOLOGY;

COCAINE-RELATED DISORDERS; HUMANS; IMMUNE SYSTEM; NERVOUS SYSTEM; SYSTEMS BIOLOGY;

EID: 84910091444     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214537747     Document Type: Article

References (103)

1. Beaulieu JM,Gainetdinov RR.The physiology, signaling, and pharmacology of dopamine receptors.Pharmacol Rev. 2011;63:182-217
2. Law PY,Wong YH,Loh HH.Molecular mechanisms and regulation of opioid receptor signaling.Annu Rev Pharmacol Toxicol. 2000;40:389-430
3. Nestler EJ.Historical review: molecular and cellular mechanisms of opiate and cocaine addiction.Trends Pharmacol Sci. 2004;25:210-8
4. Neuroscience of psychoactive substance use and dependence. Geneva: World Health Organization; 2004:
5. Quan N,Banks WA.Brain-immune communication pathways.Brain Behav Immun. 2007;21:727-35
6. Goeders NE.The HPA axis and cocaine reinforcement.Psychoneuroendocrinology. 2002;27:13-33
7. Straub RH.Complexity of the bi-directional neuroimmune junction in the spleen.Trends Pharmacol Sci. 2004;25:640-6
8. Deleo JA,Tanga FY,Tawfik VL.Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia.Neuroscientist. 2004;10:40-52
9. Heesch CM,Negus BH,Keffer JH,Snyder RWI,Risser RC,Eichhorn EJ.Effects of cocaine on cortisol secretion in humans.Am J Med Sci. 1995;310:61-4
10. Goeders NE.A neuroendocrine role in cocaine reinforcement.Psychoneuroendocrinology. 1997;22:237-59
11. Goeders NE,Bienvenu OJ,Desouza EB.Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat-brain.Brain Res. 1990;531:322-8
12. Hutchinson MR,Shavit Y,Grace PM,Rice KC,Maier SF,Watkins LR.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Pharmacol Rev. 2011;63:772-810
13. Ghosh C,Marchi N,Hossain M,Rasmussen P,Alexopoulos AV,Gonzalez-Martinez J,Yang H,Janigro D.A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain.Neurobiol Dis. 2012;46:692-700
14. Robbins TW,Everitt BJ.Drug addiction: bad habits add up.Nature. 1999;398:567-70
15. Civelli O,Bunzow JR,Grandy DK.Molecular diversity of the dopamine-receptors.Annu Rev Pharmacol Toxicol. 1993;33:281-307
16. Dalley JW,Everitt BJ.Dopamine receptors in the learning, memory and drug reward circuitry.Semin Cell Dev Biol. 2009;20:403-10
17. Nestler EJ.Molecular mechanisms of opiate and cocaine addiction.Curr Opin Neurobiol. 1997;7:713-9
18. Sulzer D.How addictive drugs disrupt presynaptic dopamine neurotransmission.Neuron. 2011;69:628-49
19. Blakely RD,DeFelice LJ,Hartzell HC.Molecular physiology of norepinephrine and serotonin transporters.J Exp Biol. 1994;196:263-81
20. Schoemaker H,Pimoule C,Arbilla S,Scatton B,Javoyagid F,Langer SZ.Sodium-dependent [H-3] cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons-Disease.Naunyn Schmiedebergs Arch Pharmacol. 1985;329:227-35
21. Zhang H,Sulzer D.Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors.Basal Ganglia. 2012;2:5-13
22. Cragg SJ,Greenfield SA.Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.J Neurosci. 1997;17:5738-46
23. Bello EP,Mateo Y,Gelman DM,Noain D,Shin JH,Low MJ,Alvarez VA,Lovinger DM,Rubinstein M.Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D-2 autoreceptors.Nat Neurosci. 2011;14:1033-8
24. Koob GF,Volkow ND.Neurocircuitry of addiction.Neuropsychopharmacol. 2010;35:217-38
25. Volkow ND,Wang GJ,Fowler JS,Tomasi D,Telang F.Addiction: beyond dopamine reward circuitry.Proc Natl Acad Sci U S A. 2011;108:15037-42
26. Everitt BJ,Dickinson A,Robbins TW.The neuropsychological basis of addictive behaviour.Brain Res Rev. 2001;36:129-38
27. Hyman SE,Malenka RC,Nestler EJ.Neural mechanisms of addiction: the role of reward-related learning and memory.Annu Rev Neurosci. 2006;29:565-98
28. Wheeler RA,Aragona BJ,Fuhrmann KA,Jones JL,Day JJ,Cacciapaglia F,Wightman RM,Carelli RM.Cocaine cues drive opposing context-dependent shifts in reward processing and emotional state.Biol Psychiatry. 2011;69:1067-74
29. Aragona BJ,Day JJ,Roitman MF,Cleaveland NA,Wightman RM,Carelli RM.Regional specificity in the real-time development of phasic dopamine transmission patterns during acquisition of a cue-cocaine association in rats.Eur J Neurosci. 2009;30:1889-99
30. Wise RA,Kiyatkin EA.Differentiating the rapid actions of cocaine.Nat Rev Neurosci. 2011;12:479-84
31. Rothman RB,Baumann MH.Monoamine transporters and psychostimulant drugs.Eur J Pharmacol. 2003;479:23-40
32. Smirnov MS,Kiyatkin EA.Cocaine action on peripheral, non-monoamine neural substrates as a trigger of electroencephalographic desynchronization and electromyographic activation following IV administration in freely moving rats.Neuroscience. 2010;165:500-14
33. Unterwald EM,Rubenfeld JM,Kreek MJ.Repeated cocaine administration up-regulates kappa-opioid and mu-opioid, but not delta-opioid receptors.NeuroReport. 1994;5:1613-6
34. Martin WR,Eades CG,Thompson JA,Huppler RE,Gilbert PE.Effects of morphine-like and nalorphine-like drugs in nondependent and morphine-dependent chronic spinal dog.J Pharmacol Exp Ther. 1976;197:517-32
35. Vaupel DB.Naltrexone fails to antagonize the sigma-effects of PCP and SKF 10,047 in the dog.Eur J Pharmacol. 1983;92:269-74
36. Su TP,Hayashi T.Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction.Curr Med Chem. 2003;10:2073-80
37. Hayashi T,Su TP.Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival.Cell. 2007;131:596-610
38. Maurice T,Su TP.The pharmacology of sigma-1 receptors.Pharmacol Ther. 2009;124:195-206
39. Su TP,Hayashi T.Cocaine affects the dynamics of cytoskeletal proteins via sigma(1) receptors.Trends Pharmacol Sci. 2001;22:456-8
40. Su TP,Hayashi T,Vaupel DB.When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor.Sci Signal. 2009;2:pe12-pe12
41. Hayashi T,Su TP.Regulating ankyrin dynamics: roles of sigma-1 receptors.Proc Natl Acad Sci U S A. 2001;98:491-6
42. Sabeti J,Nelson TE,Purdy RH,Gruol DL.Steroid pregnenolone sulfate enhances NMDA-receptor-independent long-term potentiation at hippocampal CA1 synapses: role for L-type calcium channels and sigma-receptors.Hippocampus. 2007;17:349-69
43. Martina M,Turcotte MEB,Halman S,Bergeron R.The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus.J Physiol. 2007;578:143-57
44. Chen L,Dai XN,Sokabe M.Chronic administration of dehydroepiandrosterone sulfate (DHEAS) primes for facilitated induction of long-term potentiation via sigma 1 (sigma(1)) receptor: optical imaging study in rat hippocampal slices.Neuropharmacology. 2006;50:380-92
45. Hayashi T,Su TP.Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.CNS Drugs. 2004;18:269-84
46. Matsumoto RR,McCracken KA,Pouw B,Zhang Y,Bowen WD.Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides.Neuropharmacology. 2002;42:1043-55
47. Liu Y,Matsumoto RR.Alterations in fos-related antigen 2 and sigma(1) receptor gene and protein expression are associated with the development of cocaine-induced behavioral sensitization: time course and regional distribution studies.J Pharmacol Exp Ther. 2008;327:187-95
48. Liu Y,Chen GD,Lerner MR,Brackett DJ,Matsumoto RR.Cocaine up-regulates Fra-2 and sigma-1 receptor gene and protein expression in brain regions involved in addiction and reward.J Pharmacol Exp Ther. 2005;314:770-9
49. Watson ES,Murphy JC,Elsohly HN,Elsohly MA,Turner CE.Effects of the administration of coca alkaloids on the primary immune-responses of mice – interaction with delta-9-tetrahydrocannabinol and ethanol.Toxicol Appl Pharmacol. 1983;71:1-13
50. Bagasra O,Forman L.Functional-analysis of lymphocytes subpopulations in experimental cocaine abuse.1. Dose-dependent activation of lymphocyte subsets.Clin Exp Immunol. 1989;77:289-93
51. Roth MD,Whittaker KM,Choi R,Tashkin DP,Baldwin GC.Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model.J Leukoc Biol. 2005;78:1198-203
52. Chao C,Jacobson LP,Tashkin D,Martinez-Maza O,Roth MD,Margolick JB,Chmiel JS,Rinaldo C,Zhang ZF,Detels R.Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men.Drug Alcohol Depend. 2008;94:165-71
53. Klein TW,Matsui K,Newton CA,Young J,Widen RE,Friedman H.Cocaine suppresses proliferation of phytohemagglutinin-activated human peripheral-blood T-cells.Int J Immunopharmacol. 1993;15:77-86
54. Piccotti JR,BrissetteStorkus CS,Chambers WH,Bricker JD.Suppression of splenic T lymphocyte proliferation by acute cocaine administration.Life Sci. 1997;61:967-76
55. Faraj BA,Olkowski ZL,Jackson RT.A cocaine-sensitive active dopamine transport in human-lymphocytes.Biochem Pharmacol. 1995;50:1007-14
56. Baldwin GC,Roth MD,Tashkin DP.Acute and chronic effects of cocaine on the immune system and the possible link to AIDS.J Neuroimmunol. 1998;83:133-8
57. Gardner B,Zhu LX,Roth MD,Tashkin DP,Dubinett SM,Sharma S.Cocaine modulates cytokine and enhances tumor growth through sigma receptors.J Neuroimmunol. 2004;147:95-8
58. Gan XH,Zhang L,Newton T,Chang SL,Ling W,Kermani V,Berger O,Graves MC,Fiala M.Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects.Clin Immunol Immunopathol. 1998;89:181-90
59. Pellegrino T,Bayer BM.In vivo effects of cocaine on immune cell function.J Neuroimmunol. 1998;83:139-47
60. Kubera M,Filip M,Basta-Kaim A,Nowak E,Siwanowicz J,Zajicova A,Holan V,Maes M,Lasori W.The effect of cocaine sensitization on mouse immunoreactivity.Eur J Pharmacol. 2004;483:309-15
61. Pellegrino TC,Dunn KL,Bayer BM.Mechanisms of cocaine-induced decreases in immune cell function.Int Immunopharmacol. 2001;1:665-75
62. Deng SX,Bharat N,Fischman MC,Landry DW.Covalent modification of proteins by cocaine.Proc Natl Acad Sci U S A. 2002;99:3412-6
63. Schneider KJ,DeCaprio AP.Covalent thiol adducts arising from reactive intermediates of cocaine biotransformation.Chem Res Toxicol. 2013;26:1755-64
64. Kinsey BM,Jackson DC,Orson FM.Anti-drug vaccines to treat substance abuse.Immunol Cell Biol. 2009;87:309-14
65. Orson FM,Rossen RD,Shen X,Lopez AY,Wu Y,Kosten TR.Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine.Am J Addiction. 2013;22:169-74
66. Kosten TR,Domingo CB.Can you vaccinate against substance abuse?.Expert Opin Biol Ther. 2013;13:1093-7
67. Kousik SM,Napier TC,Carvey PM.The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation.Front Pharmacol. 2012;3:121-121
68. Gan XH,Zhang L,Berger O,Stins MF,Way D,Taub DD,Chang SL,Kim KS,House SD,Weinand M,Witte M,Graves MC,Fiala M.Cocaine enhances brain endothelial adhesion molecules and leukocyte migration.Clin Immunol. 1999;91:68-76
69. Roth MD,Tashkin DP,Choi R,Jamieson BD,Zack JA,Baldwin GC.Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes.J Infect Dis. 2002;185:701-5
70. Kim SG,Jung JB,Dixit D,Rovner R,Zack JA,Baldwin GC,Vatakis DN.Cocaine exposure enhances permissiveness of quiescent T cells to HIV infection.J Leukoc Biol. 2013;94:835-43
71. Zhu LX,Sharma S,Gardner B,Escuadro B,Atianzar K,Tashkin DP,Dubinett SM.IL-10 mediates sigma(1) receptor-dependent suppression of antitumor immunity.J Immunol. 2003;170:3585-91
72. Xu W,Flick T,Mitchel J,Knowles C,Ault K.Cocaine effects on immunocompetent cells: an observation of in vitro cocaine exposure.Int J Immunopharmacol. 1999;21:463-72
73. Fischman MW,Schuster CR,Javaid J,Hatano Y,Davis J.Acute tolerance development to the cardiovascular and subjective effects of cocaine.J Pharmacol Exp Ther. 1985;235:677-82
74. Pitts DK,Udom CE,Marwah J.Cardiovascular effects of cocaine in anesthetized and conscious rats.Life Sci. 1987;40:1099-111
75. Foltin RW,Fischman MW.Smoked and intravenous cocaine in humans – acute tolerance, cardiovascular and subjective effects.J Pharmacol Exp Ther. 1991;257:247-61
76. Mendelson JH,Sholar M,Mello NK,Teoh SK,Sholar JW.Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men.Neuropsychopharmacol. 1998;18:263-71
77. Karch SB.Cocaine cardiovascular toxicity.South Med J. 2005;98:794-9
78. Restrepo C,Rojas C,Martinez S,Riascos R,Marmol-Velez A,Carrillo J,Vargas D.Cardiovascular complications of cocaine: imaging findings.Emerg Radiol. 2009;16:11-9
79. Knuepfer MM.Cardiovascular disorders associated with cocaine use: myths and truths.Pharmacol Ther. 2003;97:181-222
80. Afonso L,Mohammad T,Thatai D.Crack whips the heart: a review of the cardiovascular toxicity of cocaine.Am J Cardiol. 2007;100:1040-3
81. Lange RA,Hillis LD.Cardiovascular complications of cocaine use.N Engl J Med. 2001;345:351-8
82. Reece A.Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers.Immun Ageing. 2007;4:6-6
83. Rissin DM,Kan CW,Campbell TG,Howes SC,Fournier DR,Song L,Piech T,Patel PP,Chang L,Rivnak AJ,Ferrell EP,Randall JD,Provuncher GK,Walt DR,Duffy DC.Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations.Nat Biotechnol. 2010;28:595-9
84. Faley SL,Copland M,Wlodkowic D,Kolch W,Seale KT,Wikswo JP,Cooper JM.Microfluidic single cell arrays to interrogate signalling dynamics of individual, patient-derived hematopoietic stem cells.Lab Chip. 2009;9:2659-64
85. Berke JD,Hyman SE.Addiction, dopamine, and the molecular mechanisms of memory.Neuron. 2000;25:515-32
86. Robinson TE,Berridge KC.The neural basis of drug craving – an incentive-sensitization theory of addiction.Brain Res Rev. 1993;18:247-91
87. Self DW,Nestler EJ.Molecular mechanisms of drug reinforcement and addiction.Annu Rev Neurosci. 1995;18:463-95
88. Kuhar MJ,Pilotte NS.Neurochemical changes in cocaine withdrawal.Trends Pharmacol Sci. 1996;17:260-4
89. Kalivas PW,Stewart J.Dopamine transmission in the initiation and expression of drug-induced and stress-induced sensitization of motor-activity.Brain Res Rev. 1991;16:223-44
90. De Vries TJ,Schoffelmeer ANM,Binnekade R,Murder AH,Vanderschuren LJMJ.Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization.Eur J Neurosci. 1998;10:3565-71
91. Romieu P,Meunier J,Garcia D,Zozime N,Martin-Fardon R,Bowen WD,Maurice T.The sigma(1) (sigma(1)) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming.Psychopharmacol. 2004;175:154-62
92. Ecke LE,Cleck JN,White P,Schug J,Mifflin L,Blendy JA.CREB-mediated alterations in the amygdala transcriptome: coordinated regulation of immune response genes following cocaine.Int J Neuropsychopharmacol. 2011;14:1111-26
93. Maier SF,Watkins LR.Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition.Psychol Rev. 1998;105:83-107
94. Anisman H.Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.J Psychiatry Neurosci. 2009;34:4-20
95. Sternberg EM.Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens.Nat Rev Immunol. 2006;6:318-28
96. Tilders JH, Schmidt ED. Cross-sensitization between immune and non-immune stressors. In: Dantzer R, Wollman EE, Yirmiya R (eds) Cytokines, stress, and depression. 461 ed. New York: Springer, 1999, pp.179–97.
97. Ambroggi F,Turiault M,Milet A,Deroche-Gamonet V,Parnaudeau S,Balado E,Barik J,van der Veen R,Maroteaux G,Lemberger T,Schutz G,Lazar M,Marinelli M,Piazza PV,Tronche F.Stress and addiction: glucocorticoid receptor in dopaminoceptive neurons facilitates cocaine seeking.Nat Neurosci. 2009;12:247-9
98. Avila AH,Alonzo NC,Bayer BMInfectious diseases and substance abuse. Friedman HKlein TWBendinelli M, ed. New York: Springer; 2005:1-11.
99. Avila AH,Morgan CA,Bayer BM.Stress-induced suppression of the immune system after withdrawal from chronic cocaine.J Pharmacol Exp Ther. 2003;305:290-7
100. Avila AH,Alonzo NC,Bayer BM.Immune cell activity during the initial stages of withdrawal from chronic exposure to cocaine or morphine.J Neuroimmunol. 2004;147:109-13
101. Johnson TR,Knisely JS,Christmas JT,Schnoll SH,Ruddy S.Changes in immunologic cell surface markers during cocaine withdrawal in pregnant women.Brain Behav Immun. 1996;10:324-36
102. Pacifici R,Zuccaro P,Farre M,Pichini S,Di Carlo S,Roset PN,Palmi I,Ortuno J,Menoyo E,Segura J,de la Torre R.Cell-mediated immune response in MDMA users after repeated dose administration.Ann New York Acad Sci. 2002;965:421-33
103. Hicks MJ,De BP,Rosenberg JB,Davidson JT,Moreno AY,Janda KD,Wee S,Koob GF,Hackett NR,Kaminsky SM,Worgall S,Toth M,Mezey J,Crystal RG.Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs.Mol Ther. 2011;19:612-9